相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies
Anton Lindberg et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents
Kaixiang Zhou et al.
MOLECULAR PHARMACEUTICS (2021)
Tauvid (TM): The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease
Caitlin V. M. L. Jie et al.
PHARMACEUTICALS (2021)
Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research
Christina M. Moloney et al.
ALZHEIMERS & DEMENTIA (2021)
PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer's Disease and Other Tauopathies
Heiko Kroth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer
Frederik J. R. Rombouts et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and bioevaluation of technetium-99 m/rhenium labeled phenylquinoxaline derivatives as Tau imaging probes
Fan Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
Yi Ting Wang et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)
[18F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series
Marta Marquie et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Tau PET imaging in neurodegenerative tauopathies-still a challenge
Antoine Leuzy et al.
MOLECULAR PSYCHIATRY (2019)
Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling
N. Arul Murugan et al.
ACS CHEMICAL NEUROSCIENCE (2018)
18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal
Christopher M. Lee et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
Ruiqing Ni et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer's Disease with Positron Emission Tomography
Luca C. Gobbi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Cryo-EM structures of tau filaments from Alzheimer's disease
Anthony W. P. Fitzpatrick et al.
NATURE (2017)
Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case
Marta Marquie et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Ryuichi Harada et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F}-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
Abbas M. Walji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
An autoradiographic evaluation of AV-1451 Tau PET in dementia
Val J. Lowe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Characteristics of Tau and Its Ligands in PET Imaging
Ryuichi Harada et al.
BIOMOLECULES (2016)
[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease
Ryuichi Harada et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future
Manuela Ariza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue
Laetitia Lemoine et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study
Naruhiko Sahara et al.
NEUROBIOLOGY OF AGING (2014)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
David T. Chien et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Tau pathology and neurodegeneration
Maria Grazia Spillantini et al.
LANCET NEUROLOGY (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies
Wei Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
Michelle T. Fodero-Tavoletti et al.
BRAIN (2011)
The Revitalized Tau Hypothesis on Alzheimer's Disease
Ricardo B. Maccioni et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
PET radiotracers: crossing the blood-brain barrier and surviving metabolism
Victor W. Pike
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Novel imidazo[1,2-a]naphthyridinic systems (part 1): Synthesis, antiproliferative and DNA-intercalating activities
Mounir Andaloussi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Tau exon 10 alternative splicing and tauopathies
Fei Liu et al.
MOLECULAR NEURODEGENERATION (2008)
High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation
Alex Crowe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Imaging of CNS myelin by positron-emission tomography
B Stankoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
J Näslund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
